Miranda M. C. Rees

Keine laufenden Positionen mehr

Health Technology

Consumer Services

Profil

Ms. Miranda M.
Rees is Vice President-Product Development at Syndax Pharmaceuticals, Inc. Ms. Rees was previously employed as Head-Statistical Services by Glaxo, Inc., a Principal by Beecham Pharmaceuticals, Statistics Director by Syntex Research Centre, Statistics Director by Roche Global Development, and Vice President-Product Development by Novacea, Inc. She received her undergraduate degree from The University of Reading and a graduate degree from Columbia University.

Ehemalige bekannte Positionen von Miranda M. C. Rees

Unternehmen	Position	Ende
Roche Global Development	Corporate Officer/Principal	-
Beecham Pharmaceuticals	Corporate Officer/Principal	-
Glaxo, Inc.	Corporate Officer/Principal	-
Syntex Research Centre Syntex Research Centre Pharmaceuticals: OtherHealth Technology Syntex Research Centre is a British company that provides pharmaceutical products. Syntex Research Centre was acquired by Quintiles Scotland Ltd on February 01, 1995 for $20.68 million.	Corporate Officer/Principal	-
Novacea, Inc. Novacea, Inc. Pharmaceuticals: MajorHealth Technology Novacea, Inc. is a privately held biopharmaceutical company focused on licensing, developing and commercializing novel agents to revolutionize the treatment of cancer. Novacea’s in-licensed product portfolio features three clinical stage oncology therapeutics. The Company has two products which are anticipated to commence Phase 3 clinical trials in 2006, DN-101 and vinorelbine oral. Banoxantrone (AQ4N) is in Phase 1/2 clinical trials. It is located in South San Francisco, CA.	Corporate Officer/Principal	-

Sehen Sie sich die Erfahrung von Miranda M. C. Rees im Detail an

Ausbildung von Miranda M. C. Rees

The Trustees of Columbia University in The City of New York	Graduate Degree
The University of Reading	Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen